HETEROCYCLES, Vol. 83, No. 9, 2011
2009
5.1 Hz), 3.44 (2H, t, J = 7.8 Hz), 3.55 (2H, t, J = 7.2 Hz), 3.67 (2H, t, J = 5.1 Hz), 3.84 (2H, s), 4.15 (2H,
13
s); C NMR (CDCl3) 20.1, 34.3, 48.1, 52.4, 55.0, 59.4, 66.2, 113.5, 160.3; HRMS: calculated for
C9H15N3O3 [MH]+ 214.1192, found 214.1187.
2-(2-Methoxy-ethyl)-4-nitro-1,2,3,5,6,7-hexahydropyrrolo1,2-c]pyrimidine (18). Pale yellow crystals.
1
IR (KBr) max 1576, 1351 (NO2) cm-1; H NMR (CDCl3) 2.09 (2H, m), 2.70 (2H, t, J = 5.1 Hz), 3.34
(3H, s), 3.43 (2H, t, J = 7.8 Hz), 3.52 (2H, t, J = 5.1 Hz), 3.55 (2H, t, partly overlapped, J = 7.2 Hz), 3.86
13
(2H, s), 4.17 (2H, s); C NMR (CDCl3) 20.2, 34.2, 48.9, 52.3, 52.7, 58.9, 66.0, 71.0, 113.6, 160.1;
HRMS: calculated for C10H17N3O3 [MH]+ 228.1358, found 228.1347.
2-Benzyl-4-nitro-1,2,3,5,6,7-hexahydropyrrolo1,2-c]pyrimidine (19). Pale yellow crystals. IR (KBr)
max 1579, 1371 (NO2) cm-1; 1H NMR (CDCl3) 2.10 (2H, m), 3.46 (2H, t, J = 7.5 Hz), 3.47 (2H, t, J =
7.5 Hz), 3.69 (2H, s), 3.93 (2H, s), 4.04 (2H, s), 7.25 - 7.35 (m, 5H); 13C NMR (CDCl3) 20.3, 34.2, 48.7,
52.2, 57.6, 64.5, 113.9, 127.7, 128.5, 128.8, 137.1, 160.1; HRMS: calculated for C14H18N3O2 [MH]+
260.1399, found 260.1406.
2-2-(3,4-dimethoxyphenyl)ethyl-4-nitro-1,2,3,5,6,7-hexahydro-pyrrolo1,2-c]pyrimidine (20). Pale
yellow crystals. IR (KBr) max 1577, 1365 (NO2) cm-1; 1H NMR (CDCl3) 2.09 (2H, m), 2.69-2.83 (4H,
m), 3.42-3.52 (4H, m), 3.84 (3H, s), 3.86 (3H, s), 3.96 (2H, s), 4.09 (2H, s), 6.69-6.81 (3H, m); 13C NMR
(CDCl3) 20.2, 34.2, 34.4, 48.0, 52.3, 55.1, 55.9, 66.3, 111.4, 112.0, 113.8, 120.5, 132.0, 147.6, 149,0,
160.0; HRMS: calculated for C17H24N3O4 [MH]+ 334.1767, found 334.1763.
2-Benzyloctahydropyrrolo1,2-c]pyrimidin-4-ylamine (21 and 22). The solution of 19 (1.30 g, 5.0
mmol) in EtOH (30 mL) was hydrogenated with Raney-Ni catalyst (1.1 g) under pressure (initial pressure
0.9 MPa) at 23 oC for 6 h. After removal of the catalyst the solvent was evaporated to yield a pale yellow
oily residue (1.15 g, practically complete conversion). The crude product (1.10 g) was chromatographed
using an eluent mixture (EtOAc - CH2Cl2 - isopropylamine, 40/10/3) to produce the diastereomer 21 (595
o
mg), white crystals, mp 63-64 C, IR (KBr) max 3344, 3249, 3167 (NH), 1609, 1495 (C=C) cm-1; NMR
data of 21: s. Figure 2. and diastereomer 22 (74 mg), as a pale yellow oil. IR (liquid film) max 3400 br
1
(NH2) cm-1; H-NMR (CDCl3) 1.60-2.20 (9H, m), 2.37-2.44 (1H, m), 3.30-3.50 (3H, m), 3.47 (2H, s),
3.86 (1H, d), 7.20-7.40 (5H, m) 13C NMR (CDCl3) 21.0, 24.9, 46.9, 50.6, 59.6, 59.7, 66.8, 75.5, 126.9,
128.1, 128.7, 138.1.
Octahydropyrrolo1,2-c]pyrimidin-4-ylamine (23 and 24). The solution of the nitro compound 19 (2.20
g, 8.5 mmol in 20 mL EtOH) was hydrogenated in presence of 10% Pd/C (1.45 g) at 0.8 MPa and 20 oC.
As the hydrogen consumption ceased (about 3 h), the catalyst and the solvent was removed to yield a
colorless oil (1.0 g, 83%), predominantly the diastereomer 23.
The solution of 21 (190 mg) in EtOH (15 mL) was hydrogenated in presence of 10% Pd/C catalyst (120